Intermittent, repetitive corticosteroid-induced upregulation of platelet levels after adenovirus-mediated transfer to the liver of a chimeric glucocorticoid-responsive promoter controlling the thrombopoietin cDNA

Blood

Volumn 92, Issue 3, 1998, Pages 822-833

  Narumi, Ko ^b   Suzuki, Motoyoshi ^b   Song, Wenru ^b   Moore, Malcolm A S ^b   Crystal, Ronald G ^a  

^a WEILL CORNELL MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; THROMBOPOIETIN;

ARTICLE; GENE THERAPY; HUMAN; HUMAN CELL; MEGAKARYOCYTE; PRIORITY JOURNAL; PROMOTER REGION; THROMBOCYTE COUNT; THROMBOCYTOPOIESIS;

EID: 0032147192     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v92.3.822     Document Type: Article

References (76)

1. Miller N, Whelan J: Progress in transcriptionally targeted and regulatable vectors for genetic therapy. Hum Gene Ther 8:803, 1997
2. Brigham KL, Meyrick B, Christman B, Conary JT, King G, Berry LC Jr, Magnuson MA: Expression of human growth hormone fusion genes in cultured lung endothelial cells and in the lungs of mice. Am J Respir Cell Mol Biol 8:209, 1993
3. Wang C, Chao L, Chao J: Direct gene delivery of human tissue kallikrein reduces blood pressure in spontaneously hypertensive rats. J Clin Invest 95:1710, 1995
4. Fishman GI, Kaplan ML, Buttrick PM: Tetracycline-regulated cardiac gene expression in vivo. J Clin Invest 93:1864, 1994
5. Ho DY, McLaughlin JR, Sapolsky RM: Inducible gene expression from defective herpes simplex virus vectors using the tetracyclineresponsive promoter system. Brain Res Mol Brain Res 41:200, 1996
6. Liang X, Hartikka J, Sukhu L, Manthorpe M, Hobart P: Novel, high expressing and antibiotic-controlled plasmid vectors designed for use in gene therapy. Gene Ther 3:350, 1996
7. Suzuki M, Singh RN, Crystal RG: Regulatable promoters for use in gene therapy applications: Modification of the 5′-flanking region of the CFTR gene with multiple cAMP response elements to support basal, low-level gene expression that can be upregulated by exogenous agents that raise intracellular levels of cAMP Hum Gene Ther 7:1883, 1996
8. Suzuki M, Singh RN, Crystal RG: Pharmacologie induction of hepatic expression of a gene transferred by an adenovirus vector enabled by a chimeric promoter containing multiple cAMP response elements. Hepatology 27:160, 1997
9. Hayashi Y, De Paoli AM, Burant CF, Refetoff S: Expression of a thyroid hormone-responsive recombinant gene introduced into adult mice livers by replication-defective adenovirus can be regulated by endogenous thyroid hormone receptor. J Biol Chem 269:23872, 1994
10. Varley AW, Coulthard MG, Meideil RS, Gerard RD, Munford RS: Inflammation-induced recombinant protein expression in vivo using promoters from acute-phase protein genes. Proc Natl Acad Sci USA 92:5346, 1995
11. Hallahan DE, Mauceri HJ, Seung LP, Dunphy EJ, Wayne JD, Hanna NN, Toledano A, Hellman S, Kufe DW, Weichselbaum RR: Spatial and temporal control of gene therapy using ionizing radiation. Nat Med 1:786, 1995
12. Mader S, White JH: A steroid-inducible promoter for the controlled overexpression of cloned genes in eukaryotic cells. Proc Natl Acad Sei USA 90:5603, 1993
13. Gorman CM, Moffat LF, Howard BH: Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol Cell Biol 2:1044, 1982
14. Bartley TD, Bogenberger J, Hunt P, Li YS, Lu HS, Martin F, Chang MS, Samal B, Nichol JL, Swift S: Identification and cloning of a megakaryocyte growth and development factor that is a ligand for the cytokine receptor Mpl. Cell 77:1117, 1994
15. de Sauvage FJ, Hass PE, Spencer SD, Malloy BE, Gurney AL, Spencer SA, Darbonne WC, Henzel WJ, Wong SC, Kuang WJ, Oles KJ, Hultgren B, Solberg LA Jr, Goeddel DV, Eaton DL: Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand. Nature 369:533, 1994
16. Kaushansky K, Broudy VC, Lin N, Jorgensen MJ, McCarty J, Fox N, Zucker-Franklin D, Lofton-Day C: Thrombopoietin, the Mpl ligand, is essential for full megakaryocyte development. Proc Natl Acad Sci USA 92:3234, 1995
17. Lok S, Kaushansky K, Holly RD, Kuijper JL, Lofton-Day CE, Oort PJ, Grant FJ, Heipel MD, Burkhead SK, Kramer JM, Bell LA, Sprecher CA, Blumberg H, Johnson R, Prunkard D, Ching AFT, Mathewes SL, Bailey MC, Forstrom JW, Buddle MM, Osborn SG, Evans SJ, Sheppard PO, Presnell SR, O'Hara PJ, Hagen FS, Roth GJ, Foster DC:: Cloning and expression of murine thrombopoietin cDNA and stimulation of platelet production in vivo. Nature 369:565, 1994
18. Jantzen HM, Strahle U, Gloss B, Stewart F, Schmid W, Boshart M, Miksicek R, Schutz G: Cooperativity of glucocorticoid response elements located far upstream of the tyrosine aminotransferase gene. Cell 49:29, 1987
19. Korst RJ, Bewig B, Crystal RG: In vitro and in vivo transfer and expression of human surfactant Sp-A- and Sp-B-associated protein cDNAs mediated by replication-deficient, recombinant adenoviral vectors. Hum Gene Ther 6:277, 1995
20. McGrory WJ, Bautista DS, Graham FL: A simple technique for the rescue of early region I mutations into infectious human adenovirus type 5. Virology 163:614, 1988
21. Gorman CM, Merlino GT, Willingham MC, Pastan I, Howard BH: The Rous sarcoma virus long terminal repeat is a strong promoter when introduced into a variety of eukaryotic cells by DNA-mediated transfection. Proc Natl Acad Sci USA 79:6777, 1982
22. Boshart M, Weber F, Jahn G, Dorsch-Hasler K, Fleckenstein B, Schaffner W: A very strong enhancer is located upstream of an immediate early gene of human cytomegalovirus. Cell 41:521, 1985
23. Hersh J, Crystal RG, Bewig B: Modulation of gene expression after replication-deficient, recombinant adenovirus-mediated gene transfer by the product of a second adenovirus vector. Gene Ther 2:124, 1995
24. Graham FL, Smiley J, Russell WC, Nairn R: Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol 36:59, 1977
25. Rosenfeld MA, Yoshimura K, Trapnell BC, Yoneyama K, Rosenthal ER, Dalemans W, Fukayama M, Bargon J, Stier LE, Stratford-Perricaudet L, Perricaudet M, Guggino WB, Pavirani A, Lecocq J-P, Crystal RG: In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium. Cell 68:143, 1992
26. Rosenfeld MA, Siegfried W, Yoshimura K, Yoneyama K, Fukayama M, Stier LE, Paakko PK, Gilardi P, Stratford-Perricaudet LD, Perricaudet M, Jallat S, Pavirani A, Lecocq J-P, Crystal RG: Adenovirusmediated transfer of a recombinant alpha 1-antitrypsin gene to the lung epithelium in vivo. Science 252:431, 1991
27. Neumann JR, Morency CA, Russian KO: A novel rapid assay for chloramphenicol acetyltransferase gene expression. Biotechniques 5:444, 1987
28. Herz J, Gerard RD: Adenovirus-mediated transfer of low density lipoprotein receptor gene acutely accelerates cholesterol clearance in normal mice. Proc Natl Acad Sci USA 90:2812, 1993
29. Worgall S, Wolff G, Falck-Pedersen E, Crystal RG: Innate immune mechanisms dominate elimination of adenoviral vectors following in vivo administration. Hum Gene Ther 8:37, 1997
30. Chirgwin JM, Przybyla AE. MacDonald RJ, Rutter WJ: Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18:5294, 1979
31. Tso JY, Sun XH, Kao TH, Reece KS, Wu R: Isolation and characterization of rat and human glyceraldehyde-3-phosphate dehydrogenase cDNAs: Genomic complexity and molecular evolution of the gene. Nucleic Acids Res 13:2485, 1985
32. Thomas PS: Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose. Proc Natl Acad Sci USA 77:5201, 1980
33. Kruisbeck AM: Isolation and frac donation of mononuclcar cell populations, in Coico R (ed): Current Protocols in Immunology. New York, NY, Wiley, 1996, p 3.1.1
34. Song WR, Kong HL, Traktman P, Crystal RG: Cytotoxic T lymphocyte responses to proteins encoded by heterologous transgenes transferred in vivo by adenoviral vectors. Hum Gene Ther 8:1207, 1997
35. Mastrangeli A, Harvey BG, Yao J, Wolff G, Kovesdi I, Crystal RG, Falck-Pedersen E: "Sero-switch" adenovirus-mediated in vivo gene transfer: Circumvention of anti-adenovirus humoral immune defenses against repeat adenovirus vector administration by changing the adenovirus serotype. Hum Gene Ther 7:79, 1996
36. Fielder PJ, Gurney AL, Stefanich E, Marian M, Moore MW, Carver-Moore K, de Sauvage FJ: Regulation of thrombopoietin levels by c-Mpl-mediated binding to platelets. Blood 87:2154, 1996
37. Stefanich E, Senn T, Widmer R, Fratino C, Keller GA, Fielder PJ: Metabolism of thrombopoietin (TPO) in vivo: Determination of the binding dynamics for TPO in mice. Blood 89:4063, 1997
38. Kimura S, Roberts AW, Metcalf D, Alexander WS: Hematopoietic stem cell deficiencies in mice lacking c-Mpl, the receptor for thrombopoietin. Proc Natl Acad Sci USA 95:1195, 1998
39. Crystal RG: Transfer of genes to humans: Early lessons and obstacles to success. Science 270:404, 1995
40. Barnes PJ, Adcock IM: Glucocorticoid Receptors, in Crystal RG, West JB (eds): The Lung: Scientific Foundations. Philadelphia, PA, Lippincott-Raven, 1997, p 37
41. McEwan IJ, Wright AP, Gustafsson JA: Mechanism of gene expression by the glucocorticoid receptor: Role of protein-protein interactions. Bioessays 19:153, 1997
42. Ko MS, Nakauchi H, Takahashi N: The dose dependence of glucocorticoid-inducible gene expression results from changes in the number of transcriptionally active templates. EMBO J 9:2835, 1990
43. Hirt RP, Poulain-Godefroy O, Billotte J, Kraehenbuhl JP, Fasel N: Highly inducible synthesis of heterologous proteins in epithelial cells carrying a glucocorticoid-responsive vector. Gene 111:199, 1992
44. Oshima H, Simons SS Jr: Sequence-selective interactions of transcription factor elements with tandem glucocorticoid-responsive elements at physiological steroid concentrations. J Biol Chem 268: 26858, 1993
45. Ning YM, Sanchez ER: Potentiation of glucocorticoid receptormediated gene expression by the immunophilin ligands FK506 and rapamycin. J Biol Chem 268:6073, 1993
46. Pan L, Koontz J: Insulin enhances glucocorticoid receptormediated induction of gene expression independent of a specific insulin response element. Arch Biochem Biophys 316:886, 1995
47. Picard D, Schena M, Yamamoto KR: An inducible expression vector for both fission and budding yeast. Gene 86:257, 1990
48. Schimmer BP, Parker KL: Adrenocorticotropic hormone; adrenocortical steroids and their synthetic analogs; inhibitors of the synthesis and actions of adrenocortical hormones, in Hardman JG, Limbird LE, Molinoff PB, Ruddon RW, Oilman AG (eds): Goodman and Oilman's The Pharmacological Basis of Therapeutics. New York, NY, McGrawHill, 1996, p 1459
49. Muller M, Brenig B, Winnacker EL, Brem G: Transgenic pigs carrying cDNA copies encoding the murine Mxl protein which confers resistance to influenza virus infection. Gene 121:263, 1992
50. Wang Y, O'Malley BW Jr, Tsai SY, O'Malley BW: A regulatory system for use in gene transfer. Proc Natl Acad Sci USA 91:8180, 1994
51. Furth PA, St Onge L, Boger H, Gruss P, Gossen M, Kistner A, Bujard H, Hennighausen L: Temporal control of gene expression in transgenic mice by a tetracycline-responsive promoter, Proc Natl Acad Sci USA 91:9302, 1994
52. Gazit G, Kane SE, Nichols P, Lee AS: Use of the stress-inducible grp78/BiP promoter in targeting high level gene expression in fibrosarcoma in vivo. Cancer Res 55:1660, 1995
53. Jones SN, Jones PG, Ibarguen H, Caskey CT, Craigen WJ: Induction of the Cypla-1 dioxin-responsive enhancer in transgenic mice. Nucleic Acids Res 19:6547, 1991
54. Koh GY, Kim SJ, Klug MG, Park K, Soonpaa MH, Field LJ: Targeted expression of transforming growth factor-beta 1 in intracardiac grafts promotes vascular endothelial cell DNA synthesis. J Clin Invest 95:114, 1995
55. La Gamma EF, Strecker RE, Lenn NJ, De Cristofaro JD, Weisinger G: Dopaminergic regulation of a transfected preproenkephalin promoter in primary rat astrocytes in vitro and in vivo. Exp Neurol 130:304, 1994
56. Passman RS, Fishman GI: Regulated expression of foreign genes in vivo after germline transfer. J Clin Invest 94:2421, 1994
57. Lu B, Federoff HJ: Herpes simplex virus type 1 amplicon vectors with glucocorticoid-inducible gene expression. Hum Gene Ther 6:419, 1995
58. Ramirez A, Vidal M, Bravo A, Larcher F, Jorcano JL: A 5′-upstream region of a bovine keratin 6 gene confers tissue-specific expression and hyperproliferation-related induction in transgenic mice. Proc Natl Acad Sci USA 92:4783, 1995
59. Shockett P, Difilippantonio M, Hellman N, Schatz DG: A modified tetracycline-regulated system provides autoreguiatory, inducible gene expression in cultured cells and transgenic mice. Proc Natl Acad Sci USA 92:6522, 1995
60. Smith JD, Wong E, Ginsberg M: Cytochrome P450 1A1 promoter as a genetic switch for the regulatable and physiological expression of a plasma protein in transgenic mice. Proc Natl Acad Sci USA 92:11926, 1995
61. No D, Yao TP, Evans RM: Ecdysone-inducible gene expression in mammalian cells and transgenic mice. Proc Natl Acad Sci USA 93:3346, 1996
62. Rivera VM, Clackson T, Natesan S, Pollock R, Amara JF, Keenan T, Magari SR, Phillips T, Courage NL, Cerasoli F Jr, Holt DA, Gilman M: A humanized system for pharmacologie control of gene expression. Nat Med 2:1028, 1996
63. Bohl D, Naffakh N, Heard JM: Long-term control of erythropoietin secretion by doxycycline in mice transplanted with engineered primary myoblasts. Nat Med 3:299, 1997
64. Setoguchi Y, Danel C, Crystal RG: Stimulation of erythropoiesis by in vivo gene therapy: Physiologic consequences of transfer of the human erythropoietin gene to experimental animals using an adenovirus vector. Blood 84:2946, 1994
65. Liu Y, Liggitt D, Zhong W, Tu G, Gaensler K, Debs R: Cationic liposome-mediated intravenous gene delivery. J Biol Chem 270:24864, 1995
66. Ohwada A, Rafii S, Moore MA, Crystal RG: In vivo adenovirus vector-mediated transfer of the human thrombopoietin cDNA maintains platelet levels during radiation- and chemotherapy-induced bone marrow suppression. Blood 88:778, 1996
67. Rosenthal FM, Fruh R, Henschler R, Veelken H, Kulmburg P, Mackensen A, Gansbacher B, Mertelsmann R, Lindemann A: Cytokine therapy with gene-transfected cells: Single injection of irradiated granulocyte-macrophage colony-stimulating factor-transduced cells accelerates hematopoietic recovery after cytotoxic chemotherapy in mice. Blood 84:2960, 1994
68. Tripathy SK, Black HB, Goldwasser E, Leiden JM: Immune responses to transgene-encoded proteins limit the stability of gene expression after injection of replication-defective adenovirus vectors. Nat Med 2:545, 1996
69. Yan XQ, Lacey D, Hill D, Chen Y, Fletcher F, Hawley RG, McNiece IK: A model of myelofibrosis and osteosclerosis in mice induced by overexpressing thrombopoietin (Mpl ligand): Reversal of disease by bone marrow transplantation. Blood 88:402, 1996
70. Cannizzo SJ, Frey BM, Raffi S, Moore MAS, Eaton D, Suzuki M, Singh R, Mack CA, Crystal RG: Augmentation of blood platelet levels by intratracheal administration of an adenovirus vector encoding human thrombopoietin cDNA. Nat Biotechnol 15:570, 1997
71. Hillman RS: Hematopoietic agents: Growth factors, minerals, and vitamins, in Hardman JG, Limbird LE, Molinoff PB, Ruddon RW, Gilman AG (eds): Goodman and Gillman's The Pharmacological Basis of Therapeutics. New York, NY, McGraw-Hill, 1996, p 1311
72. Barr D, Tubb J, Ferguson D, Scaria A, Lieber A, Wilson C, Perkins J, Kay MA: Strain related variations in adenovirally mediated transgene expression from mouse hepatocytes in vivo: Comparisons between immunocompetent and immunodeficient inbred strains. Gene Ther 2:151, 1995
73. Fang B, Wang H, Gordon G, Bellinger DA, Read MS, Brinkhous KM, Woo SL, Eisensmith RC: Lack of persistence of El-recombinant adenoviral vectors containing a temperature-sensitive E2A mutation in immunocompetent mice and hemophilia B dogs. Gene Ther 3:217, 1996
74. Poller W, Schneider-Rasp S, Liebert U, Merklein F, Thalheimer P, Haack A, Schwaab R, Schmitt C, Brackmann HH: Stabilization of transgene expression by incorporation of E3 region genes into an adenoviral factor IX vector and by transient anti-CD4 treatment of the host. Gene Ther 3:521, 1996
75. Yang Y, Jooss KU, Su Q, Ertl HC, Wilson JM: Immune responses to viral antigens versus transgene product in the elimination of recombinant adenovirus-infected hepatocytes in vivo. Gene Ther 3:137, 1996
76. Wadsworth SC, Zhou HS, Smith AE, Kaplan JM: Adenovirus vector-infected cells can escape adenovirus antigen-specific cytotoxic T-lymphocyte killing in vivo. J Virol 71:5189, 1997